Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Theodore James Alkousakis

TitleClinical Associate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-DERM General Operations
Phone720/848-0530

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. McMichael A, Shahriari M, Stein Gold L, Alkousakis T, Choi O, Bhutani T, Rodriguez AO, Tyring SK, Chan D, Rowland K, Albrecht L, Lynde C, Yadav G, Yeung J, Park-Wyllie L, Ma T, Jeyarajah J, Gao LL, Smith S, Moore AY, Vashi N, Kindred C, Grimes P, Desai SR, Taylor SC, Alexis A. Guselkumab for Moderate to Severe Scalp Psoriasis Across All Skin Tones: Cohort B of the VISIBLE Randomized Clinical Trial. JAMA Dermatol. 2025 Sep 01; 161(9):912-922. PMID: 40560554.
      View in: PubMed
    2. Alexis A, McMichael A, Soung J, Choi O, Alkousakis T, Alonso-Llamazares J, Shahriari M, Rodriguez AO, Bhutani T, Chan D, Rowland K, Sauder M, Hong HC, Yadav G, Yeung J, Jeyarajah J, Ma T, Gao LL, Park-Wyllie L, Green L, Lee M, Vashi N, Kindred C, Grimes P, Taylor SC, Desai SR. Guselkumab for Moderate to Severe Psoriasis Across All Skin Tones: Cohort A of the VISIBLE Randomized Clinical Trial. JAMA Dermatol. 2025 Sep 01; 161(9):901-911. PMID: 40560559.
      View in: PubMed
    3. Stein Gold L, Gottlieb AB, Armstrong AW, Alkousakis T, Bissonnette R, Langley RG, Krueger J, Papp K, Choi O, Rowland K, Chan D, Jeyarajah J, Park-Wyllie L, Gao LL, Gordon KB, Merola JF, Lebwohl MG, Strober B. SPECTREM Phase 3b Clinical Trial Results Through Week 16: Guselkumab Efficacy and Safety for the Treatment of Low Body Surface Area, Moderate Psoriasis With High-Impact Site Involvement. Br J Dermatol. 2025 Aug 28. PMID: 40875818.
      View in: PubMed
    4. Armstrong AW, Feldman SR, Fitzgerald T, Alkousakis T, Sima A, Li A, Kang HJ, Main SI, Khattri S, Stein Gold L. Patient-Reported Outcomes by Baseline Body Surface Area Involvement Among Individuals Initiating Biologic Therapy: Results from the CorEvitas Psoriasis Registry. Dermatol Ther (Heidelb). 2025 Aug; 15(8):2117-2130. PMID: 40498388.
      View in: PubMed
    5. Alexis A, McMichael A, Vashi N, Bhutani T, Rodriguez AO, Yeung J, Choi O, Chan D, Alkousakis T, Bronner DN, Park-Wyllie L, Gao LL, Grimes P, Shahriari M, Yadav G, Kindred C, Taylor SC, Desai SR. Improving Diversity in a Novel Psoriasis Study: VISIBLE as a Framework for Clinical Trial Quality Improvement. JAMA Dermatol. 2025 Mar 01; 161(3):256-264. PMID: 39661358.
      View in: PubMed
    6. Browning RJ, Fathi R, Smith MA, Alkousakis T. Flagellate Shiitake Mushroom Reaction With Histologic Features of Acute Generalized Exanthematous Pustulosis. Cutis. 2021 Sep; 108(3):E8-E10. PMID: 34826284.
      View in: PubMed
    7. Gamboa J, Cameron MC, Fathi R, Alkousakis T. A review of non-pharmacologic approaches to enhance the patient experience in dermatologic surgery. Dermatol Online J. 2020 Mar 15; 26(3). PMID: 32609440.
      View in: PubMed
    8. Pearson DR, Lewis K, Alkousakis T. Remote-onset alopecia areata attributed to ipilimumab. Cutis. 2019 Dec; 104(6):E25-E27. PMID: 31939941.
      View in: PubMed
    9. Prince GT, Cameron MC, Fathi R, Alkousakis T. Topical 5-fluorouracil in dermatologic disease. Int J Dermatol. 2018 Oct; 57(10):1259-1264. PMID: 30187924.
      View in: PubMed
    10. Del Rosario F, Farahi JM, Drendel J, Buntinx-Krieg T, Caravaglio J, Domozych R, Chapman S, Braunberger T, Dellavalle RP, Norris DA, Fathi R, Alkousakis T. Performance of a computer-aided digital dermoscopic image analyzer for melanoma detection in 1,076 pigmented skin lesion biopsies. J Am Acad Dermatol. 2018 05; 78(5):927-934.e6. PMID: 29678380.
      View in: PubMed
    11. Farahi JM, Fazzari M, Braunberger T, Caravaglio JV, Kretowicz A, Wells K, Dellavalle RP, Norris D, Alkousakis T. Gender differences in melanoma prognostic factors. Dermatol Online J. 2018 Apr 15; 24(4). PMID: 29905998.
      View in: PubMed
    12. Prince GT, Cameron MC, Fathi R, Alkousakis T. Intralesional and Laser-Assisted 5-Fluorouracil in Dermatologic Disease: A Systematic Review. J Drugs Dermatol. 2018 Mar 01; 17(3):274-280. PMID: 29537445.
      View in: PubMed
    13. Snow SC, Pearson DR, Fathi R, Alkousakis T, Winslow CY, Golitz L. Heparin-induced haemorrhagic bullous dermatosis. Clin Exp Dermatol. 2018 Jun; 43(4):393-398. PMID: 29282761.
      View in: PubMed
    14. Snyder BM, Mounessa JS, Fazzari M, Caravaglio JV, Kretowicz A, Braunberger T, Wells K, Dunnick CA, Dellavalle RP, Alkousakis T. Greater distance to an academic medical center is associated with poorer melanoma prognostic factors: The University of Colorado Experience. Dermatol Online J. 2017 Nov 15; 23(11). PMID: 29447632.
      View in: PubMed
    15. Fathi R, Alkousakis T, Brown M. Plaque-Like Atypical Fibroxanthoma, A Rare Invasive Variant. Dermatol Surg. 2017 Jan; 43(1):138-139. PMID: 27399943.
      View in: PubMed
    16. Hegg RM, Alkousakis TJ, Swick BL. What is your diagnosis? Old world Leishmaniasis. Cutis. 2014 Feb; 93(2):67;69;70. PMID: 24605349.
      View in: PubMed
    17. Tillou A, Weng J, Alkousakis T, Velmahos G. Fascial dehiscence after trauma laparotomy: a sign of intra-abdominal sepsis. Am Surg. 2003 Nov; 69(11):927-9. PMID: 14627249.
      View in: PubMed
    Alkousakis's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (105) concept(s)
    _
    Co-Authors Expand Description
    See all (1) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)